Literature DB >> 5125851

Model experiments on the molecular mechanism of action of 6-hydroxydopamine.

A Saner, H Thoenen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5125851

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN： 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  20 in total

1.  Hydroxybenzaldoximes Are D-GAP-Competitive Inhibitors of E. coli 1-Deoxy-D-Xylulose-5-Phosphate Synthase.

Authors:  David Bartee; Francine Morris; Amer Al-Khouja; Caren L Freel Meyers
Journal:  Chembiochem       Date:  2015-07-15       Impact factor: 3.164

Review 2.  Parkinson's disease: what the model systems have taught us so far.

Authors:  Swagata Ghatak; Dorit Trudler; Nima Dolatabadi; Rajesh Ambasudhan
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 3.  Role of nitric oxide on motor behavior.

Authors:  E A Del Bel; F S Guimarães; M Bermúdez-Echeverry; M Z Gomes; A Schiaveto-de-souza; F E Padovan-Neto; V Tumas; A P Barion-Cavalcanti; M Lazzarini; L P Nucci-da-Silva; D de Paula-Souza
Journal:  Cell Mol Neurobiol       Date:  2005-03       Impact factor: 5.046

4.  Interaction between 6-hydroxydopamine and rhodopsin in vivo in the rat retina.

Authors:  S F Pong; L T Graham
Journal:  Experientia       Date:  1974-08-15

5.  A role for the p75 neurotrophin receptor in axonal degeneration and apoptosis induced by oxidative stress.

Authors:  Bradley R Kraemer; John P Snow; Peter Vollbrecht; Amrita Pathak; William M Valentine; Ariel Y Deutch; Bruce D Carter
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157

6.  Fine structure of the male genital tract and kidney in the Anura Xenopus laevis Daudin, Rana temporaria L. and Bufo bufo L. under normal and experimental conditions.

Authors:  K Unsicker
Journal:  Cell Tissue Res       Date:  1975       Impact factor: 5.249

7.  Sympathetic denervation caused by long-term noradrenaline infusions; prevention by desipramine and superoxide dismutase.

Authors:  A Albino Teixeira; I Azevedo; D Branco; E Rodrigues-Pereira; W Osswald
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

Review 8.  Animal models of Parkinson's disease progression.

Authors:  Gloria E Meredith; Patricia K Sonsalla; Marie-Francoise Chesselet
Journal:  Acta Neuropathol       Date:  2008-02-14       Impact factor: 17.088

Review 9.  Actinobacterial melanins: current status and perspective for the future.

Authors:  Panchanathan Manivasagan; Jayachandran Venkatesan; Kannan Sivakumar; Se-Kwon Kim
Journal:  World J Microbiol Biotechnol       Date:  2013-04-18       Impact factor: 3.312

10.  Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson's disease.

Authors:  Renata Pietsch Ribeiro; Eduardo Luiz Gasnhar Moreira; Danúbia Bonfanti Santos; Dirleise Colle; Alessandra Antunes Dos Santos; Kaite Cristiane Peres; Claudia Pinto Figueiredo; Marcelo Farina
Journal:  Neurochem Res       Date:  2013-01-19       Impact factor: 3.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.